All of Us Research Program Set to Open National Enrollment

May 01, 2018

|

NEW YORK (GenomeWeb) – The National Institutes of Health today announced that the All of Us Research Program will begin enrolling participants nationwide this coming Sunday, May 6.

All of Us is a critical component of the Precision Medicine Initiative, which President Barack Obama launched in 2015. The research program aims to enroll 1 million Americans willing to donate biological samples and share a variety of data from electronic medical records, surveys, wearables, and genetic testing that researchers can use to learn more about diseases and develop treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

A 'Double Whammy'

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

So Much Plastic

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

With a Little Lemon?

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

Science Has a Trio of Ruminant Genome Studies and More

In Science this week: three studies from the Ruminant Genome Project, and more.

Featured White Papers

Cell Engineering 101

Improved CRISPR Knockout Efficiency Using an Automated Optimization Workflow

CRISPR 101

Gene Knockouts: How CRISPR Is Used to Inactivate Genes

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu